Clinical Enzymology Cardiac markers Flashcards
Type of cardiovascular disease affecting the heart
Coronary heart disease
Manifestation of coronary heart disease
Angina/angina pectoris (chest pain), acute myocardial infarction
Type of cardiovascular disease affecting the brain
Cerebrovascular diseases
Conditions under cerebrovascular diseases
Stroke, transient ischemic attacks (lack of blood supply)
Type of cardiovascular disease associated with ischemic conditions
Peripheral arterial disease
Symptoms of peripheral arterial disease
Acute localized pain in arms and legs
Type of cardiovascular disease associated with increased blood pressure
Aortic Atherosclerotic Disease
Cause of aortic atherosclerotic disease
Build-up of fatty streaks or plaques
Complication of aortic atherosclerotic disease
Formation of blood clots
Consequence of abnormal weakening of the artery
Aneurysm
Condition related to tears in the thoracic or abdominal aorta
Aortic dissection
Types of cardiac markers
Myoglobin, CK-MB, Troponin I, Troponin T, CK, LDH
Angina also known as
Chest pain
Type of angina after strenuous activity without underlying injury
Stable angina
Characteristics of stable angina
Activity-related, no increase in cardiac markers
Type of angina associated with acute myocardial infarction
Unstable angina
Effect of unstable angina on cardiac markers
Increases cardiac markers
Classic manifestation of angina
Chest pain (squeezing pain), burning feeling, difficulty in breathing
CK isoenzymes
CK-BB (CK-1), CK-MB (CK-2), CK-MM (CK-3)
CK-BB (CK-1) characteristics
Widely distributed, not detected normally, fastest in electrophoresis
CK-MB (CK-2) characteristics
Found in the heart
CK-MM (CK-3) characteristics
Present in skeletal muscle and the heart
Tissue sources of CK
Brain, Heart, Skeletal muscle
Pronounced elevation of CK (>5x UL)
Duchenne’s muscular dystrophy, polymyositis, dermatomyositis, myocardial infarction
Mild to moderate elevation of CK (2-4x UL)
Acute agitated psychosis, alcoholic myopathy, severe exercise, delirium tremens, severe ischemic injury, pulmonary infarction, intramuscular injections, hypothyroidism, muscular trauma
Reference range for CK in males
15–160 U/L
Reference range for CK in females
15–130 U/L
CK-MB normal percentage of total CK
<6% of total CK
Main form of CK in serum
94%-100% is CK-MM
Cofactor and activator of CK
Magnesium Ion
CK isoenzyme with fastest migration to the anode
CK-BB (CK-1)
CK isoenzyme found in the heart
CK-MB (CK-2)
CK isoenzyme present in skeletal muscle and heart
CK-MM (CK-3)
Non-clinically significant CK isoenzyme
Macro-CK
CK isoenzyme associated with immunoglobulin and seen between CK-MM and CK-MB
Macro-CK
CK isoenzyme detected in extensive tissue damage and poor prognosis
Mitochondrial-CK
CK isoenzyme detected in malignant tumors and cardiac abnormalities
Mitochondrial-CK
Specimen consideration for CK determination
Avoid prolonged storage (CK1 most labile), avoid chelators and gross hemolysis (adenylate kinase)
Total CK analysis method with decreasing pattern
Tanzer-Gilvarg (Forward method)
pH for Tanzer-Gilvarg method
Alkaline at 9.0
Reaction in Tanzer-Gilvarg method
Creatine to creatine phosphate conversion, Diphosphate reacts with phosphoenolpyruvate (uses pyruvate kinase)